First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocin

Eur J Clin Microbiol Infect Dis. 2003 May;22(5):318-9. doi: 10.1007/s10096-003-0929-z. Epub 2003 May 8.

Authors

J W Decousser¹, P Pina, J C Ghnassia, J P Bedos, P Y Allouch

Affiliation

¹ Department of Hospital Health, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157, Le Chesnay Cedex, France. [email protected]

PMID: 12736798
DOI: 10.1007/s10096-003-0929-z

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Carrier State*
Drug Resistance, Multiple, Bacterial*
Glycopeptides / pharmacology*
Humans
Intensive Care Units
Male
Methicillin Resistance*
Microbial Sensitivity Tests
Mupirocin / pharmacology*
Mupirocin / therapeutic use
Respiratory Insufficiency / diagnosis
Respiratory Insufficiency / etiology
Sensitivity and Specificity
Severity of Illness Index
Staphylococcal Infections / diagnosis
Staphylococcal Infections / drug therapy*
Staphylococcus aureus / drug effects*
Staphylococcus aureus / isolation & purification

Substances

Glycopeptides
Mupirocin